Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancerType I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer, Published online: 13 December 2018; doi:10.1038/s41388-018-0624-2Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Source: Oncogene - December 13, 2018 Category: Cancer & Oncology Authors: Qiang Lan Sanam Peyvandi Nathalie Duffey Yu-Ting Huang David Barras Werner Held Fran çois Richard Mauro Delorenzi Christos Sotiriou Christine Desmedt Girieca Lorusso Curzio R üegg Source Type: research